Biotech Specialty Pharma

PrognostiX

10265 Carnegie Avenue
Cleveland, OH 44106 USA
Phone
Fax
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Molecular Biomarker Technologies and Diagnostics for Cardiovascular and Immunological Applications

Management Jake Orville, President and CEO; Shaohong Liang, M.D., Director, Monoclonal Antibody and Assay Development Laboratory; Weijia Wu, Ph.D., Director, Product Development and Reference Laboratory; Scott F. Purvis, Director, Operations; Rachele Rhea, Manager, Customer Support

Click here for Financial Data
Keywords: Cardiology, Diagnostics, Immunology. Molecular Biomarkers, Inflammation, Assay

Comment


Updated: Aug. 22, 2013


Description

PrognostiX is a specialty diagnostics company and reference laboratory focused on molecular biomarker technologies and the creation or proprietary diagnostic tests that address critical unmet needs in......view more

Products / Services

CardioMPO is an enzyme immunoassay intended for the quantitative determination of myeloperoxidase in human plasma, to be used in conjunction with clinical history, ECG and cardiac biomarkers in evalua......view more

Technology / Differentiation

The CardioMPO Assay is a sandwich enzyme-linked immunosorbent assay (ELISA) that uses two highly specific monoclonal antibodies for the measurement of MPO concentration in human lithium heparin plasma...view more

Market / Customers

The company's customers include hospitals, cardiologists, emergency rooms, reference labs and physicians' offices.......view more


Status

PrognostiX has a significant pipeline of assays that are protected by intellectual property and target large, under-addressed markets. The company has achieved annual revenue of approximately $1.4 mil...view more

RELATED COMPANIES